New Brain Scan Insights for MS and iNPH Diagnosis

New Brain Scan Insights for MS and iNPH Diagnosis
Credibility
Interest
Key Takeaway

Doctors may use a special brain scan to help diagnose a condition called idiopathic normal pressure hydrocephalus (iNPH) in patients with MS and other diseases.

What They Found

The study looked at brain scans of patients with iNPH, Alzheimer's disease (AD), and healthy people. It found that the choroid plexus (a part of the brain that makes fluid) was larger in iNPH patients compared to those with AD and healthy individuals. This is important because it means that doctors might be able to tell if someone has iNPH just by looking at this size difference in brain scans. The study also confirmed that the size of the choroid plexus and another brain area called the lateral ventricle were useful in making this diagnosis. Essentially, a bigger choroid plexus could help doctors figure out what's wrong more accurately.

Who Should Care and Why

This finding is significant for MS patients who may have symptoms similar to iNPH, like problems with movement or memory. Caregivers and family members can benefit by understanding why doctors might recommend certain brain scans and what the results could mean. If a doctor can diagnose iNPH early, patients may receive better treatment sooner, which could improve their daily lives. This could be like catching a problem early so it doesn't become a bigger issue later. Overall, knowing about these findings helps everyone involved in care to work better together.

Important Considerations

The study only looked at a small number of patients, so more research is needed to confirm these results. Also, the focus was on iNPH, which is a different condition than MS, so the findings may not apply directly to MS itself. Patients and caregivers should discuss any concerns with their healthcare provider to understand how these results relate specifically to their situation.

Article Topics:
Choroid plexusDiagnosisIdiopathic normal pressure hydrocephalus

You May Also Like

Gut Bacteria and MS: What You Need to Know
Gut Bacteria and MS: What You Need to Know

12/31/2026

Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li

Read More
CD29: A Blood Clue to MS B Cells and Treatment Response
CD29: A Blood Clue to MS B Cells and Treatment Response

5/1/2026

Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in

Read More
What MS Patients Should Know About PML and Recovery
What MS Patients Should Know About PML and Recovery

5/1/2026

Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes

Read More
Fewer Hospital Cases of Certain Brain Autoimmunity During COVID
Fewer Hospital Cases of Certain Brain Autoimmunity During COVID

5/1/2026

Study found fewer hospital diagnoses of antibody-positive autoimmune encephalitis during COVID-19, b

Read More
New option to reduce damage in NMOSD attacks
New option to reduce damage in NMOSD attacks

3/1/2026

Study shows C5 inhibitors given during or soon after NMOSD attacks helped most patients stabilize or

Read More
Quick Eye Scan Helps Tell Two Serious Optic Nerve Conditions Apart
Quick Eye Scan Helps Tell Two Serious Optic Nerve Conditions Apart

3/1/2026

Early OCT eye scans can often distinguish MOGAD from NMOSD optic neuritis, helping guide faster trea

Read More
Understanding MS Research

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.